C91.A2
C91.A2 — Mature B-cell leukemia Burkitt-type, in relapse
Billable / specific codeICD-10-CM
C91.A2 is a billable, specific ICD-10-CM code for mature b-cell leukemia burkitt-type, in relapse. It is valid for submission on a claim.
Risk adjustment
C91.A2 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 20 Lung and Other Severe Cancers1.136 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.
Medicare coverage
C91.A2 is named in 32 Medicare coverage policies — 32 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
Related codes at this level
Codes that share C91.A. If C91.A2 is not quite right, the correct code is usually one of these.
Questions about C91.A2
- Is C91.A2 a billable ICD-10-CM code?
- Yes. C91.A2 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does C91.A2 sit in the tabular list?
- Neoplasms (C00-D49), in the block Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96).